Aurora Cannabis To Buy CanniMed Therapeutics For $1.1 Billion

Aurora Cannabis Inc. has struck a friendly deal valued at $1.1 billion to buy rival licensed producer CanniMed Therapeutics Inc., ending a hostile takeover battle between the Canadian marijuana companies.

“We are very pleased to have come to terms with CanniMed on this powerful strategic combination that will establish a best-in-class cannabis company with operations across Canada and around the world,” Aurora chief executive Terry Booth said. Continue reading “Aurora Cannabis To Buy CanniMed Therapeutics For $1.1 Billion”